Document is current
Any future updates will be listed below
-
Authors
Larsson, Mark https://orcid.org/0000-0002-0361-1013
Sartipy, Ulrik
Franco-Cereceda, Anders
Öwall, Anders
Jakobsson, Jan
-
Funding
Funding for this research was provided by:
Grünenthal Sweden AB (2-2191/2020)
Hjärt-Lungfonden (20190533)
Karolinska Institute
- License Information
-
More Information
Article History
Received: 15 December 2021
Accepted: 9 June 2022
First Online: 20 June 2022
Declarations
:
: The study was approved by the Swedish Ethical Review authority (registration number: 2019-05120). The principal investigator will obtain written informed consent from each study participant.
: Each patient who is asked to participate in the trial will receive written information that has been approved by the Swedish Ethical Review authority as part of the application for ethical consent. This information states that the results of the trial will be published in a scientific paper. After oral information about the trial and the possibility to ask questions, the principal investigator (ML) will obtain written consent from each study participant.
: The authors declare that they have no competing interests.
